Early Initiated Ambulance-delivered Levetiracetam and Headposition in Hyper-acute Stroke Trial

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 2423 participants.

Also called NCT06773364

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 2,423 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06773364
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT06773364. Randomized; single masking; primary purpose treatment. Start 2025-04-30 (actual); primary completion 2028-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Early Initiated Ambulance-delivered Levetiracetam and Headposition in Hyper-acute Stroke Trial
Acronym
EAST
Condition
Suspected Stroke
Intervention (Drug)
Levetiracetam
Intervention (Other)
Guide-recommended management
Intervention (Other)
The lying flat (0°) head position
Intervention (Other)
The sitting-up (≥30°) head position
Lead sponsor
Shanghai East Hospital (class: other)

Record details

Record id
cardio:ct-nct06773364
Content hash
408990dd8eade53ecd0e08c09e291fabaaedc1ed7e449d42962e5f388e75fbec